Healthcare shares are generally trading flat in pre-market trade.
Forest Labs ( FRX ) is up about 8% pre-market as it reports Q3 EPS of $0.27, well ahead of the analyst consensus of $0.06 per share on Capital IQ. Sales were $846.8 mln, vs. expectations of $826 mln.
For FY 2014, the company expects EPS of $1.25-$1.35, vs.the Street view of $1.12 per share. The company also approved a stock buyback of up to $1 billion.
And, Johnson & Johnson ( JNJ ) shares are nudging up pre-market after the pharmaceuticals company said its Q4 adjusted income rose 5.5%, topping analysts' forecasts on Capital IQ.
The company reported adjusted net earnings of $3.6 billion, or $1.24 per diluted share, beating the consensus view by $0.04. Revenue gained 4.5% to $18.35 billion, also topping estimates for $17.9 billion.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.